Ledger.Open graph →
SEC Form D · filed October 15, 2021

Angiocrine Bioscience, Inc

Offering
$99.4M
Sold
$58.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

John Jaskowiak · San Diego, CAExecJohn Lomoro · San Diego, CAExecPaul Finnegan · CHICAGO, ILExec · DirectorJeffrey Port · San Diego, CADirectorMarc Cohen · Cambridge, MADirectorJeff Jonas · Cambridge, MADirectorDavid Parkinson · Gaithersburg, MDDirectorMarc Cohen · North Andover, MADirectorJeff Jonas · Cambridge, MADirectorJohn Jaskowiak · San Diego, CAExecJohn Lomoro · San Diego, CAExecDavid Parkinson · Houston, TXDirectorPaul Finnegan · Solana Beach, CAExec · DirectorJeffrey Port · Bellevue, WADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗